Corvus Pharmaceuticals, Inc. (CRVS) — Dilution Risk Analysis
Current Snapshot
Corvus Pharmaceuticals, Inc. (CRVS) has a DilutionWatch score of 62/10 and is classified as HIGH risk. The score date in the source data is 2026-10-03T03:45:52.527348.
This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.
Dilution Risk Score
Score: 62/10 Source (as of 2026-10-03T03:45:52.527348)
Recent SEC Filings
3 shelf registration or ATM offering filings detected in recent history.
Recent filing forms in the source payload: 8-K 3, 424B5 3, 4 1, XBRL 2.
| Form | Filed | Accession |
|---|---|---|
| 8-K | 2026-04-23 | 0001104659-26-047735 |
| 424B5 | 2026-03-13 | 0001104659-26-027382 |
| 8-K | 2026-03-13 | 0001104659-26-027390 |
| 4 | 2026-01-30 | 0000947871-26-000079 |
| 424B5 | 2026-01-23 | 0001104659-26-005967 |
| 8-K | 2026-01-23 | 0001104659-26-005968 |
| 424B5 | 2026-01-20 | 0001104659-26-005113 |
| xbrl | 2025-12-31 | xbrl-3114-xbrl_convertible |
| xbrl | 2025-12-31 | xbrl-3114-xbrl_warrant |
Dilution Risk Drivers
| Driver | Stored Value | Source |
|---|---|---|
| ATM offering capacity remaining | $200,000,000 | Source |
| Cash runway | 7 months | Source |
| Three-year share count growth | 9999.0% | Source |
DilutionWatch Analysis
- Risk Level
- HIGH (Score: 62/10) Source
- Cash Runway
- 7 months Source
- ATM Offering Capacity Remaining
- $200,000,000 Source
- Share Count Growth (3-Year)
- 9999.0% Source
What This Page Does Not Estimate
DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.
Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.